LOGO 872
Pill imprint LOGO 872 has been identified as Glipizide extended release 5 mg.
Glipizide is used in the treatment of diabetes, type 2 and belongs to the drug class sulfonylureas. Risk cannot be ruled out during pregnancy.
Glipizide 5 mg is not subject to the Controlled Substances Act.
See also related documents.
Glipizide extended release Images
- Imprint:
-
LOGO 872
- Strength:
- 5 mg
- Color:
- White
- Size:
- 8.00 mm
- Shape:
- Round
- Availability:
- Prescription only
- Inactive Ingredients:
- polyethylene glycol
hypromellose
magnesium stearate
sodium chloride
ferric oxide red
cellulose acetate
- Drug Class:
- Sulfonylureas
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Andrx Pharmaceuticals
- National Drug Code (NDC):
- 62037-0872
| NDC Code | Manufacturer / Repackager |
|---|---|
| 58016-0334 | Southwood Pharmaceuticals Inc (repackager) |
| 57866-6302 | Direct Dispensing Inc (repackager) |
Note: Inactive ingredients may vary.
Advertisement
More GlipiZIDE Extended Release resources
- Glipizide
- Glipizide (Wolters Kluwer)
- Glipizide Extended-Release Tablets (Wolters Kluwer)
- glipizide (Cerner Multum)
- glipizide (Micromedex) - Includes Dosage Information
- Glipizide (AHFS DI)
- Glipizide (FDA)
- Glipizide ER (FDA)
- Glipizide Tablets (FDA)
- Glipizide (Wolters Kluwer)
Search Again
